Tech & Science AI-Designed Drugs by a DeepMind Spinoff Are Headed to Human Trials
Isomorphic Labs president Max Jaderberg said at WIRED Health in London that the startup has built a “broad and exciting pipeline of new medicines.”
By
· April 24, 2026 · 1 min read
This article was originally published by
Wired
and is republished here under license.
Isomorphic Labs president Max Jaderberg said at WIRED Health in London that the startup has built a “broad and exciting pipeline of new medicines.”
Like this:
Like Loading...
Related
In late 2025, Google started rolling out new icons with a gradient design. Now it seems the new look is…
By
· April 26, 2026 · 1 min read
Within hours of an armed gunman's attempt to enter the White House Correspondents Dinner, attended by top administration officials and…
By
· April 26, 2026 · 1 min read
Before Coachella, Tomora wasn't on my radar at all. It's actually only by chance that I stumbled upon them -…
By
· April 26, 2026 · 1 min read
Leave a Reply